Target intelligence / Profile preview

U3 small nucleolar RNA-associated protein 18 homolog, pseudogene

Molecular classification
Other (pseudogene)
01

Overview

U3 small nucleolar RNA-associated protein 18 homolog, pseudogene (also known as ENSG00000267293 or LOC100422497) is annotated as a **pseudogene** in the human genome[3]. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically do not encode functional proteins and do not serve as drug targets, disease drivers, or biomarkers. This pseudogene appears related by sequence to the functional gene UTP18, which encodes a ribosome biogenesis factor, but there is no evidence that the pseudogene itself is transcribed or translated, nor that it has a direct biological or disease role[3][7]. Additional context: This entry should not be used as a therapeutic target, and there is no evidence that it functions as a receptor, enzyme, transporter, or other classic drug target. The confusion may arise from similarity to the functional UTP18 gene[5][7], but ENSG00000267293 specifically represents a non-functional pseudogene copy. Summary of issues: - This is a pseudogene, not an active molecular target[3]. - Not suitable for therapeutic targeting or research as a biomarker or therapy mechanism. - No known protein product, function, disease link, or drug interaction. If you are seeking information on the functional, protein-coding form, refer instead to the UTP18 gene (U3 small nucleolar RNA-associated protein 18 homolog, human, functional gene)[5][7].

Other names
LOC100422497ENSG00000267293

Beyond the preview

Go deeper on U3 small nucleolar RNA-associated protein 18 homolog, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on U3 small nucleolar RNA-associated protein 18 homolog, pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call